USP38 and chronic kidney disease: Treatment with AST-120, an oral adsorbent that lowers serum indoxyl sulfate (IS) and other protein-bound uremic toxins (Tsai et al. 2023), significantly attenuated the CKD-induced upregulation of USP38 in vivo (Supplementary Figure S1G).